Literature DB >> 30807784

HOX cluster-embedded antisense long non-coding RNAs in lung cancer.

Lianlian Li1, Yong Wang2, Guoqiang Song3, Xiaoyu Zhang4, Shan Gao4, Hongyan Liu5.   

Abstract

Homeobox (HOX) genes play vital roles in embryonic development and oncogenesis. In humans, there are 39 HOX genes found in four clusters that are located on different chromosomes. The HOX clusters also contain numerous non-protein-coding RNAs, including some lncRNAs. The HOX cluster-embedded lncRNAs (HOX-lncRNAs), most notably, HOTTIP and HOTAIR play a major role in the regulation of their adjacent coding genes. Recently, most HOX-lncRNAs have been shown to impact tumorigenesis and cancer progression. Several HOX-lncRNAs, including HOTTIP, HOXA11-AS, HOTAIRM1, HOXA-AS3, HOXA10-AS, HOTAIR, and HAGLR, are dysregulated in lung cancer. Moreover, their expression levels are correlated with the clinical features of this disease. These HOX-lncRNAs regulate the proliferation, invasion, migration, and chemo-resistance of lung cancer cells through various molecular mechanisms. Although lncRNAs have received much attention lately, the functions of some HOX-lncRNAs in the development of cancer are unclear. Thus, HOX-embedded lncRNAs should be widely investigated in cancer. Here, we review the functions of HOX-lncRNAs in lung cancer.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Homeobox gene; LncRNA; Therapeutic target

Year:  2019        PMID: 30807784     DOI: 10.1016/j.canlet.2019.02.036

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

Review 1.  The Role of LncRNAs in Uveal Melanoma.

Authors:  Paula Milán-Rois; Anan Quan; Frank J Slack; Álvaro Somoza
Journal:  Cancers (Basel)       Date:  2021-08-11       Impact factor: 6.575

2.  Increased expression of HOXA11-AS attenuates endometrial decidualization in recurrent implantation failure patients.

Authors:  Hanting Zhao; Shuanggang Hu; Jia Qi; Yuan Wang; Ying Ding; Qinling Zhu; Yaqiong He; Yao Lu; Yue Yao; Shiyao Wang; Yanzhi Du; Yun Sun
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

Review 3.  Exosomal Long Non-Coding RNAs in Lung Diseases.

Authors:  Christophe Poulet; Makon-Sébastien Njock; Catherine Moermans; Edouard Louis; Renaud Louis; Michel Malaise; Julien Guiot
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

4.  Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence.

Authors:  Peng-Yu Chen; Xiao-Dong Li; Wei-Ning Ma; Han Li; Miao-Miao Li; Xin-Yu Yang; Shao-Yi Li
Journal:  Onco Targets Ther       Date:  2020-06-03       Impact factor: 4.147

5.  A Novel LncRNA, AC091729.7 Promotes Sinonasal Squamous Cell Carcinomas Proliferation and Invasion Through Binding SRSF2.

Authors:  Boyu Yu; Linmei Qu; Tianyi Wu; Bingrui Yan; Xuan Kan; Xuehui Zhao; Like Yang; Yushan Li; Ming Liu; Linli Tian; Yanan Sun; Qiuying Li
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

6.  Long noncoding RNA PSMA3‑AS1 functions as a microRNA‑409‑3p sponge to promote the progression of non‑small cell lung carcinoma by targeting spindlin 1.

Authors:  Lingling Wang; Lei Wu; Jinfeng Pang
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

7.  LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.

Authors:  Liting Jin; Chenggang Luo; Xinhong Wu; Manxiu Li; Shun Wu; Yaojun Feng
Journal:  Aging (Albany NY)       Date:  2021-08-10       Impact factor: 5.682

8.  Bioinformatics analysis of the expression of HOXC13 and its role in the prognosis of breast cancer.

Authors:  Changyou Li; Junwei Cui; Li Zou; Lizhang Zhu; Wei Wei
Journal:  Oncol Lett       Date:  2019-11-22       Impact factor: 2.967

Review 9.  Long Noncoding RNAs, New Critical Regulators in Cancer Immunity.

Authors:  Minjie Wu; Peifen Fu; Lei Qu; Jian Liu; Aifu Lin
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

10.  HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.

Authors:  Jiangyan Yin; Yi Guo
Journal:  Cancer Med       Date:  2021-07-17       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.